Cancer Vaccines and Immunotherapy: Latest Advances, Limitations and Prospects

Dear Colleagues,

We invite you to participate in this Special Issue dedicated to the latest advancements and future prospects in cancer vaccines and immunotherapy. This Special Issue aims to enhance our understanding of the potential of cancer vaccines and immunotherapy, as well as their limitations, and provide insights for improving their effectiveness. We welcome original research articles and reviews covering a range of topics, including the latest advances in cancer vaccines and immunotherapy, their impact on the immune system and the response to cancer cells, and their combination with other cancer therapies. We also welcome studies based on the effectiveness of these treatments in cancer management, their potential for preventing cancer recurrence, as well as any potential side effects and risks associated with them. Additionally, we encourage submissions addressing the challenges and limitations of using cancer vaccines and immunotherapy in clinical practice and offering approaches to improve their efficacy and accessibility to cancer patients. We look forward to receiving your valuable contributions to this Special Issue.

Prof. Dr. Eyad Elkord
Dr. Afsheen Raza
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.